fenfluramine that is believed to cause adverse CVD effects by stimulating mitotic activity, resulting in cell overgrowth within the valve leaflets [19]. Owing to its high selectivity (15-fold and 100-fold more than that for 5-HT2a and 5-HT2b receptors, respectively) for the 5-HT2c receptor...